Chugai Pharmabody Research
Garvita Gupta is a Principal Scientist at Chugai Pharmabody Research. Prior to this, Garvita worked as a Postdoctoral Research Fellow at Duke-NUS Medical School and as a Research Fellow at National University of Singapore. Garvita has a Ph.D. in Structural Biology from National University of Singapore and a Master's Degree in Marine Biotechnology from Goa University. During their career, Garvita has conducted research projects focusing on immune responses, protein structures, and purification techniques.
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.